Please wait a minute...
European Journal of Gynaecological Oncology  2020, Vol. 41 Issue (5): 841-844    DOI: 10.31083/j.ejgo.2020.05.2079
Case Report Previous articles | Next articles
Appendix invasion of squamous cell carcinoma arising from ovarian mature cystic teratoma and resistant to combination chemotherapy with docetaxel and oxaliplatin: a case report
Yanan Li1, Dongge Wang1, Xiaodong Li1, Wangchao Zhang1, Xianghua Huang1, *(), Yibin Liu1
1Department of Obstetrics and Gynecology, the Second Hospital of Hebei Medical University, 215 Heping West Road, Shijiazhuang 050000, China
Download:  PDF(550KB)  ( 84 ) Full text   ( 10 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Ovarian squamous cell carcinoma arising from mature cystic teratoma is extremely rare. Our study adds to our understanding of this rare but ominous tumor. Herein we report a case of squamous cell carcinoma in a mature cystic teratoma of the right ovary in a 56-year-old woman presenting with pelvic mass and abdominal pain. Histopathological examination after exploratory laparoscopy revealed squamous cell carcinoma arising from an ovarian mature cystic teratoma with appendix invaded. The patient subsequently underwent complete debulking surgery. Unfortunately, the tumour was refractory to combined chemotherapy with docetaxel and oxaliplatin, the patient refused further treatment and passed away six months after the operation.
Key words:  Chemotherapy      Mature cystic teratoma      Ovary      Squamous cell carcinoma     
Submitted:  02 February 2020      Accepted:  26 April 2020      Published:  15 October 2020     
*Corresponding Author(s):  XIANGHUA HUANG     E-mail:  huangxh2003@163.com

Cite this article: 

Yanan Li, Dongge Wang, Xiaodong Li, Wangchao Zhang, Xianghua Huang, Yibin Liu. Appendix invasion of squamous cell carcinoma arising from ovarian mature cystic teratoma and resistant to combination chemotherapy with docetaxel and oxaliplatin: a case report. European Journal of Gynaecological Oncology, 2020, 41(5): 841-844.

URL: 

https://ejgo.imrpress.com/EN/10.31083/j.ejgo.2020.05.2079     OR     https://ejgo.imrpress.com/EN/Y2020/V41/I5/841

[1] Yu Hui Lim, Sheow Lei Lim, Linda Xiao Hui Lin, Lay Tin Soh, Hoon Seng Khoo Tan, Richard Ming Chert Yeo, Timothy Yong Kuei Lim. Sequential Chemoradiation versus Radiation for the Adjuvant Treatment of Stage III Endometrioid Adenocarcinoma of the Uterus[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 705-712.
[2] T. Uehara, A. Mitsuhashi, M. Shozu. The impact of pre-existing polycystic ovary syndrome on endometrial cancer recurrence[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 668-674.
[3] Yan qin Zhang, Di Wu, Meng qi Deng, Xiang yu Chang, Jin wei Miao, Yu mei Wu. Individual management of cervical cancer during pregnancy[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 833-837.
[4] Joseph J. Noh, Sir-Yeon Hong, Byeong-gie Kim. Malignant perivascular epithelioid cell tumor (PEComa) of uterus: A case report with literature review[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 495-499.
[5] Chados Nikolaos, Gregoriou Odysseas, Salakos Nicolaos, Kondis Agatha, Deligeoroglou Efthymios. The prognostic significance and immuno-expression of survivin, mutant p53 and bcl-2 in 92 cases of epithelial ovarian cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 517-522.
[6] Krittiya Somaketarin, Charuwan Tantipalakorn, Kittipat Charoenkwan, Prapaporn Suprasert, Jatupol Srisomboon. Survival outcomes of sex cord-stromal tumors of the ovary[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 563-568.
[7] Sigit Purbadi, Gregorius Tanamas, Lisa Novianti. Advanced stage ovarian cancer survival in Jakarta[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 587-590.
[8] U Chul Ju, Woo Dae Kang, Seok Mo Kim. Fatal hemorrhage from rupture of metastatic tumors rapidly developed after optimal primary surgery for ovarian angiosarcoma arising from a mature cystic teratoma[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 640-643.
[9] T. Shoji, E. Takatori, M. Kagabu, M. Futagami, Y. Yokoyama, H. Tokunaga, N. Yaegashi, T. Ohta, T. Watanabe, T Sugiyama. Relationship between usefulness of irinotecan and pegylated liposomal doxorubicin therapy and the UGT1A1 genotype in patients with recurrent ovarian cancer (TGCU 104 study)[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 380-385.
[10] H. Ishibashi, M. Miyamoto, T. Aoyama, H. Soyama, H. Matsuura, H. Iwahashi, M. Takano, K. Furuya. The effect of six scheduled cycles of neoadjuvant chemotherapy on prognosis in advanced ovarian cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 386-390.
[11] B. Barczyński, K. Frąszczak, M. Bilski, J. Szumiło, I. Wertel, M. Sobstyl, G. Polak, L. Grzybowska-Szatkowska, J. Kotarski. Malignancy-transformed mature cystic teratoma surgical treatment requires comprehensive staging procedures including pelvic/para-aortic lymphadenectomy[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 484-488.
[12] X.F. Xu, Q. Li, A.Y. Dai, H.J. Zhou, J.X. Ling. Neoadjuvant chemotherapy followed by radical surgery for Stage IB2 cervical cancer in pregnancy[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 489-491.
[13] Chenchen Zhu, Hanyuan Liu, Zhen Shen, Yanhu Xie, Tianjiao Zhang, Björn Nashan, Dabao Wu, Ying Zhou. Treatment and survival outcomes from epithelial ovarian cancer in women aged 65 years or older[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 415-421.
[14] M. Szarszewska, J. Markowska, A. Czekała, P. Kurzawa. Coexistence of endocervical cancer and Brenner tumor of the ovary. Diagnostic difficulties[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 299-302.
[15] X. Guo, Z. Cheng, L. Liang, M. Shao, H. Jin, J. Luo. Small cell carcinoma of the ovary hypercalcemic type (SCCOHT): report of three cases and literature review[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 303-307.
[1] Eli M. Roth, Michael H. Davidson. PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety[J]. Reviews in Cardiovascular Medicine, 2018, 19(S1): 31 -46 .
[2] B. Soltész, J. Lukács, A. Penyige, R. Póka, B. Nagy. Determination of miR-193b rs30236 single nucleotide polymorphism in ovarian cancer patients[J]. European Journal of Gynaecological Oncology, 2019, 40(4): 547 -550 .
[3] Y. Li, C. Li, N. Li, L. Jiang, W. Yang, Y. Wang, B. Wu, C. Shi, Z. Zhu. RNAi silenced NUP88 gene suppresses growth and invasiveness of human breast cancer cell line MCF-7[J]. European Journal of Gynaecological Oncology, 2019, 40(4): 634 -639 .
[4] M. Pakiž, L. Lukman, N. Kozar. Patients' and physicians' expectations differ significantly during the follow-up period after completion of primary treatment of gynecological or breast cancer[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 781 -786 .
[5] T. Tomimatsu, S. Mabuchi, T. Tsuboyama, Y. Hori, S. Sekine, T. Kimura. Malignant transformation of uterine leiomyoma: suggested by clinical, imaging, histological, and genetic findings[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 879 -882 .
[6] Z. Protrka, P. Arsenijevic, N. Jovic, S. Zivanovic, J. Djuric, A. Dimitrijevic. A case of uterine torsion in term pregnancy associated with placental abruption and intrauterine fetal demise[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(2): 287 -289 .
[7] T. Ueno, H. Yabushita, K. Iwasaki, A. Wakatsuki. Role of adiponectin and leptin in non-diabetic, non-obese patients with endometrial cancer[J]. European Journal of Gynaecological Oncology, 2018, 39(2): 199 -204 .
[8] P. Pimsi, W. Santimaleeworagun, S. Therasakvichya, N. Saengsukkasemsak, A. Laocharoenkeat. The incidence and risk factors of severe neutropenia and febrile neutropenia due to chemotherapy among gynecologic cancer patients in Thailand[J]. European Journal of Gynaecological Oncology, 2018, 39(2): 242 -246 .
[9] F. Lai-Tiong. Dermatomyositis revealing a 18-year breast cancer recurrence[J]. European Journal of Gynaecological Oncology, 2018, 39(2): 292 -293 .
[10] M.F. Benoit, K.A. O'Hanlan, M.S. Sten, C.L. Kosnik, D.M. Struck, M.S. O'Holleran, J. Cuff, D.M. Halliday, E.A. Kent. Incidental appendectomy at the time of gynecologic surgery[J]. European Journal of Gynaecological Oncology, 2018, 39(3): 386 -389 .